# A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled BIIB080 Co-administered With BIIB080 in Healthy Adults

> **NCT06454721** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 5 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** [89Zr]Zr-DFO-BIIB080
- **DRUG:** BIIB080

## Key facts

- **NCT ID:** NCT06454721
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-30
- **Primary completion:** 2026-03-05
- **Final completion:** 2026-03-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06454721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06454721, "A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled BIIB080 Co-administered With BIIB080 in Healthy Adults". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06454721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*